78 related articles for article (PubMed ID: 37002577)
21. Therapeutic potential of vasculogenic mimicry in urological tumors.
Lin X; Long S; Yan C; Zou X; Zhang G; Zou J; Wu G
Front Oncol; 2023; 13():1202656. PubMed ID: 37810976
[TBL] [Abstract][Full Text] [Related]
22. Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment.
Proto MC; Fiore D; Bifulco M; Gazzerro P
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686233
[TBL] [Abstract][Full Text] [Related]
23. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Glaviano A; Foo ASC; Lam HY; Yap KCH; Jacot W; Jones RH; Eng H; Nair MG; Makvandi P; Geoerger B; Kulke MH; Baird RD; Prabhu JS; Carbone D; Pecoraro C; Teh DBL; Sethi G; Cavalieri V; Lin KH; Javidi-Sharifi NR; Toska E; Davids MS; Brown JR; Diana P; Stebbing J; Fruman DA; Kumar AP
Mol Cancer; 2023 Aug; 22(1):138. PubMed ID: 37596643
[TBL] [Abstract][Full Text] [Related]
24. Dysregulated Signalling Pathways Driving Anticancer Drug Resistance.
Bou Antoun N; Chioni AM
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569598
[TBL] [Abstract][Full Text] [Related]
25. The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies.
Nitulescu GM; Stancov G; Seremet OC; Nitulescu G; Mihai DP; Duta-Bratu CG; Barbuceanu SF; Olaru OT
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513232
[TBL] [Abstract][Full Text] [Related]
26. Towards a Unified Approach in Autoimmune Fibrotic Signalling Pathways.
Sisto M; Lisi S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240405
[TBL] [Abstract][Full Text] [Related]
27. The PDGF/PDGFR pathway as a drug target.
Papadopoulos N; Lennartsson J
Mol Aspects Med; 2018 Aug; 62():75-88. PubMed ID: 29137923
[TBL] [Abstract][Full Text] [Related]
28. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis.
Cao Y
Trends Mol Med; 2013 Aug; 19(8):460-73. PubMed ID: 23773831
[TBL] [Abstract][Full Text] [Related]
29. PDGF/PDGFR signaling and targeting in cancer growth and progression: Focus on tumor microenvironment and cancer-associated fibroblasts.
Gialeli C; Nikitovic D; Kletsas D; Theocharis AD; Tzanakakis GN; Karamanos NK
Curr Pharm Des; 2014; 20(17):2843-8. PubMed ID: 23944365
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
31. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies.
Pandey P; Khan F; Upadhyay TK; Seungjoon M; Park MN; Kim B
Biomed Pharmacother; 2023 May; 161():114491. PubMed ID: 37002577
[TBL] [Abstract][Full Text] [Related]
32. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review.
Zou X; Tang XY; Qu ZY; Sun ZW; Ji CF; Li YJ; Guo SD
Int J Biol Macromol; 2022 Mar; 202():539-557. PubMed ID: 35074329
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
